Afinida, Inc. (TREP) has an overall financial health rating of C- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-04-08.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-04-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
